Bulletin
Investor Alert

Century Therapeutics Inc.

NAS: IPSC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 31, 2023, 6:34 p.m.

/zigman2/quotes/210490648/composite

$

3.57

Change

+0.10 +2.88%

Volume

Volume 3,630

Quotes are delayed by 20 min

/zigman2/quotes/210490648/composite

Previous close

$ 3.40

$ 3.47

Change

+0.07 +2.06%

Day low

Day high

$3.37

$3.55

Open

52 week low

52 week high

$3.37

$14.00

Open

Annual Financials for Century Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 2019202020212022 5-year trend
Sales/Revenue ----5.2M
Cost of Goods Sold (COGS) incl. D&A -249,0001.4M4.58M10.07M
COGS excluding D&A -----
Depreciation & Amortization Expense -249,0001.4M4.58M10.07M
Depreciation -249,0001.4M4.58M10.07M
Amortization of Intangibles -----
Gross Income -(249,000)(1.4M)(4.58M)(4.87M)
2019202020212022 5-year trend
SG&A Expense -19.78M47.77M90.3M118.96M
Research & Development -14.27M39.68M75.65M97.17M
Other SG&A -5.52M8.09M14.65M21.79M
Other Operating Expense -----
Unusual Expense -225.95M4.72M-10M
EBIT after Unusual Expense -(245.98M)(53.9M)-(133.83M)
Non Operating Income/Expense -1.21M704,000377,0004.42M
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense --381,0001.28M1.43M
Gross Interest Expense --381,0001.28M1.43M
Interest Capitalized -----
Pretax Income -(244.77M)(53.58M)(95.78M)(130.84M)
Income Tax ---43,00091,000
Income Tax - Current Domestic -----
Income Tax - Current Foreign ----86,000
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign ----5,000
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income -(244.77M)(53.58M)(95.82M)(130.93M)
Minority Interest Expense -----
Net Income -(244.77M)(53.58M)(95.82M)(130.93M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries -(244.77M)(53.58M)(95.82M)(130.93M)
Preferred Dividends -----
Net Income Available to Common -(244.77M)(53.58M)(95.82M)(130.93M)
EPS (Basic) ---(1.74)(2.27)
Basic Shares Outstanding ---55.01M57.76M
EPS (Diluted) ---(1.74)(2.27)
Diluted Shares Outstanding ---55.01M57.76M
EBITDA -(19.78M)(47.77M)(90.3M)(113.76M)
Link to MarketWatch's Slice.